Gillian Carleton

4PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 24, 2025
Autophagy disruption primes CAR-T cell metabolism for sustained rejection of ovarian tumors.

Gillian A Carleton, Sébastien Levesque, Lauren G Zacharias

|Feb 22, 2024
Metabolic engineering for optimized CAR-T cell therapy.

Sarah J McPhedran, Gillian A Carleton, Julian J Lum

|Feb 01, 2021
1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer.

Marisa K Kilgour, Sarah MacPherson, Lauren G Zacharias

|Jun 08, 2019
Autophagy metabolically suppresses CD8<sup>+</sup> T cell antitumor immunity.

Gillian Carleton, Julian J Lum

Pageof 1